Introduction {#Sec1}
============

Terpenoids, also referred to as terpenes, are one of the largest and the most diverse group of natural products accounting for more than 40,000 individual compounds, with several new compounds being discovered every year.

They are synthesized from only two five-carbon isomers: isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). Two biosynthetic routes have been characterized: the classical acetate mevalonate pathway (described in 1967) and the triose phosphate-utilizing non-mevalonate pathway characterized in 2002. Starting from the universal precursors IPP and DMAPP, thousands of enzymes are involved in the biosynthetic pathways for terpenoid chain elongation, cyclization, and functionalization of hydrocarbon chains. The active isoprene unit (IPP) is repetitively added to DMAPP or a prenyl diphosphate in sequential head-to-tail condensations catalyzed by the prenyltrans-ferases. Through consecutive condensations a prenyltransferase can synthesize a variety of products with fixed lengths and stereochemistry (Fig. [1](#Fig1){ref-type="fig"}) (Wang et al. [@CR135]; Ajikumar et al. [@CR4]). Based on the number of the building blocks, terpenoids are commonly classified into hemi-, mono-, sesqui-, di-, ses-, tri- and tetraterpenoids (carotenoids) having 1, 2, 3, 4, 5, 6 and 8 isoprenoid residues respectively, and polyterpenes consisting of long chains of many isoprene units (Koch et al. [@CR81]).Fig. 1Biosynthetic pathways of terpenes (Wang et al. [@CR135])

Terpenoids display a wide range of biological activities. Monoterpenes and sesquiterpenes are the main constituents of essential oils and share responsibility for important properties like antibacterial, antiviral, antioxidant etc. Triterpene saponins---ginsenosides---significantly reduce the production of beta-amyloid which accumulates in the brain of patients with Alzheimer's disease and play a critical role in pathology by inducing neuronal death. Ginkgolides (cyclic diterpenes of labdane type commonly isolated from *Ginkgo biloba*) protect neuronal cells from synaptic damage (Yoo and Park [@CR165]). However the antimalarial drug Artemisininn and the anticancer drug paclitaxel (TaxolR) are two renowned terpene-based drugs with established medical applications. Artemisinin, earlier known as *Qinghaosu*, is a phytoconstituent isolated from *Artemisia annua* L. and can be described as a compound which possess antimalarial activity. Clinical studies with patients infected with *Plasmodium vivax* or *P. falciparum* demonstrated that artemisinin could kill the malarial parasite very quickly at the schizont stage of the parasite's life cycle (i.e. when it infects the human red blood cell) with no obvious side effects. The molecule has a completely new antimalarial prototype structure with an endoperoxide moiety, which is necessary for activity. Since artemisinin itself has poor bioavailability limiting its effectiveness, several semisynthetic derivatives of artemisinin have been developed (Medhi et al. [@CR102]; Brown [@CR11]). Taxol, a plant diterpenoid widely used as a chemotherapeutic drug against several types of cancer, is known to interact with a specific site of β-tubulin---it binds to microtubules and inhibits their disassembly. Cells treated with taxol are arrested in mitosis and eventually undergo death by apoptosis. This very important activity is strongly depended on its unusual structure. It was shown that the side chain at position C-13 and the taxane ring system are essential for this activity (Xiang et al. [@CR149]).

The purification of natural products is a complex process requiring a comprehensive range of techniques. CCC offers the natural product scientist a different mode of operation to conventional processes. Invented in the mid 1960's (Ito et al. [@CR74]), to many scientists it is still known as it was back then---a technique that is slow, with separations measuring in hours or days. It was also unreliable as instruments frequently broke down and furthermore had poor capacity with injection amounts measured in tens of milligrams. There was also no opportunity for scale up as the factors required to scale up were poorly understood. However, the technique has been substantially developed since those early days. Advances in engineering and the understanding of the processes involved, particularly in the past 10 years, have created instruments that are fast, robust, permit very high injection loadings and, significantly for the natural products industry, can be rapidly scaled from analytical to pilot level (Sutherland and Fisher [@CR128]). The new generation of coil planet centrifuges operate at higher "*g*" fields than conventional instruments, enabling higher flow rates to be used so that separation times are measured in minutes rather than hours at the same resolution (Yuan et al. [@CR168]). With a number of important advantages over both solid phase chromatographic techniques and current liquid--liquid extraction techniques, modern high capacity counter-current chromatography is a worthy inclusion in the array of techniques required for natural product purifications.

Theoretical background of CCC {#Sec2}
=============================

In a counter-current chromatography centrifuge, tubing is wound on a drum which is centrifugally rotated in planetary motion (the holder rotates about its own axis while revolving around the centrifuge axis at the same angular velocity in the same direction) (Fig. [2](#Fig2){ref-type="fig"}). A two phase solvent system is introduced into this coil. Although a simple solvent system might consist of hexane and water, a more likely system for a purification would consist of hexane, ethyl acetate, methanol and water or, for biomolecules sensitive to organic solvents, an aqueous two phase system such as aqueous PEG1000 and potassium phosphate salt solution. With the two phase solvent system inside, as the coil travels through its planetary motion cycle, zones of mixing and settling travel along the phases coincident with the low and high accelerations caused by the epicyclic motion of the coil. The mixing zones are coincident with low accelerations and take the form of wave mixing, equivalent to the "swish-swosh" motion that occurs when a tube of liquids is tilted from side to side. The settling zones are coincident with high accelerations and take the form of a smooth interfacial area. There is one mixing and one settling zone per coil loop per revolution. A typical modern analytical CCC instrument may have 40 loops and spin at 2,000 rpm. It will therefore experience 4.8 million partitioning steps per hour (40 × 2,000 × 60). Similarly, a typical preparative instrument may have 30 loops and spin at 1,200 rpm, giving 2.2 million partitioning steps per hour.Fig. 2Motion of the bobbin in the CCC centrifuge (Sutherland et al. [@CR130])

Counter-current chromatography can be achieved not only in the above mentioned hydrodynamic CCC created by two axis of rotation, but also as hydrostatic CCC, typically represented by centrifugal partition chromatography (CPC). This is a single-axis instrument, which has a series of chambers machined circumferentially around a rotor. Rotation of the rotor produces a uniform g-field, which retains the stationary phase in each chamber, while the mobile phase is flowed though in a cascading manner. A CPC instrument requires rotating seals for the mobile phase flow, whereas the hydrodynamic CCC instruments do not. This is because the rotation of the coil about its own axis unwinds the twist produced by its motion around the sun gear, and thus there is no twisting of the flow tubes linking the coil to the pump and the detector (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3Type-J planetary motion of a multilayer coil separation column presenting that the column holder rotates about its own axis and revolves around the centrifuge axis at the same angular velocity (*ω*) in the same direction (Ito [@CR73])

Solvent selection process {#Sec3}
=========================

In the past, selection of a suitable two phase solvent system involved a considerable amount of experience and know-how. With aqueous-organic phase systems coming from up to six or more different solvents mixed together, the possibilities were almost limitless. A typical mid-polarity selection table is shown in Table [1](#Tab1){ref-type="table"} (Garrard [@CR45]). This is a modified version of the table produced by Oka et al. ([@CR105]) and runs from moderately polar (System No1: butanol--water) to moderately nonpolar (System No28: heptane--methanol). The italicized systems in the table can be used to rapidly screen the whole table first, allowing the operator to focus into the correct area of interest. Being all multiples of 0.5 ml when 4 ml solvent system is made, these particular systems are quick to make up and test. It is also possible to create the solvent systems on a micro-scale in 96 well plates if the crude sample is in short supply.Table 1Table for selecting a suitable moderately polar two-phase solvent system, graded from polar (No1) to nonpolar (No28)NoHeptaneEtOAcMeOHButanolWater*100022*200.401.62300.801.22401.200.82501.600.42*602002*70.11.90.101.980.21.80.201.890.291.710.2901.71100.331.670.3301.67110.41.60.401.6*120.51.50.501.5*130.571.430.5701.43140.671.330.6701.33150.81.20.801.2160.911.090.9101.09*1711101*181.090.911.0900.91191.20.81.200.8201.330.671.3300.67211.430.571.4300.57*221.50.51.500.5*231.60.41.600.4241.670.331.6700.33251.710.291.7100.29261.80.21.800.2271.90.11.900.1*2820200*Quantities (in ml) required to make 4 ml of system using a liquid-handling robot. EtOAc = ethyl acetate, MeOH = methanol. Hexane may be used instead of heptane (Garrard [@CR45])

In order to achieve an efficient resolution of the target compounds, the *K* values, which express the solute concentration in the stationary phase divided by that in the mobile phase, should be calculated. The partition coefficient (*K*) should lie within the approximate range 0.5 \< *K* \< 2.0. A smaller *K* value results in a loss of peak resolution, whilst a larger value produces excessive band broadening.

Solvent systems employed in CCC for terpenoid purification {#Sec4}
==========================================================

In order to fully assess the use of two phase systems in CCC of terpenoids, approximately 3,500 scientific papers were studied, published in the last 30 years, that related to all aspects of CCC or CPC. Papers that contained an application example of terpenoids, i.e. a purification performed by CCC or CPC were noted, together with the compounds purified and the solvent system used for the purification. Papers which gave examples of separations reported elsewhere were ignored, as were all symposium abstracts. Only papers which gave specific details of the solvent system and solute were recorded and only natural product secondary metabolites were noted e.g. no synthetic compounds, dyes or chemicals.

In total therefore, 150 solvent systems were listed in Table [2](#Tab2){ref-type="table"} together with the corresponding solutes that they separated. Some of the solvent systems corresponded to more than one solute, and some of the solutes corresponded to more than one solvent system, but if the same solute and the same solvent system were listed, this was simply a duplicate entry and was therefore removed.Table 2Solvent systems in CCC for terpenoids separationsClasses of compoundsPurified compoundsReferencesType of apparatus/solvent systemMonoterpenoidsPaeoniflorin\
AlbiflorinHuang et al. ([@CR71])CCC/ethyl acetate--*n*-butanol--water (3:2.5:5)Rosiridin\
Geranyl 1-*O*-α-[l]{.smallcaps}-arabinopyranosyl-(1→6)-β-[d]{.smallcaps}-glucopyranosideMudge et al. ([@CR103])CCC/ethyl acetate--butanol--water (3:2:5)(*S*)-3,7-Dimethyl-5-octene-1,7-diolKnapp et al. ([@CR80])CCC/chloroform--methanol--water (7:13:8)Thymol\
CarvacrolPuertas Mejia et al. ([@CR109])CCC/*n*-hexane--*tert*-butylmethyl ether--acetonitrile (1:0.1:1)EugenolGeng et al. ([@CR49])CCC/n-hexane--ethyl acetate--methanol--water (1:0.5:1:0.5)Chavibetol\
Methyleugenoldos Santos et al. ([@CR26])CCC/*n*-hexane--n-butanol--methanol--water (12:4:4:3)α-CyperoneShi et al. ([@CR121])CCC/*n*-hexane--ethyl acetate--methanol--water (1:0.2:1.1:0.2)1,8-CineoleDang et al. ([@CR22])CPC/petroleum ether--acetonitrile--acetone (4:3:1)PaeoniflorinChen et al. ([@CR13])CCC/n-butanol--ethyl acetate--water (1:4:5)Cuminaldehyde\
*p*-Menta-1,4-dien-7-alChen et al. ([@CR15])CCC/n-hexane--methanol--water (5:4:1)Linalol\
Terpinen-4-ol\
α-TerpineolSkalicka-Woźniak et al. ([@CR125])CCC/heptane--ethyl acetate--methanol--water (5:2:5:2)Anethole\
FoeniculinSkalicka-Woźniak et al. ([@CR125])CCC/heptane--methanol (1:1)SesquiterpenoidsParthenolide\
11,13-Dihydroparthenolide\
Anhydroverlotorin\
3β-Hydroxycostunolide\
Costunolide diepoxide\
3-Hydroxyparthenolide\
Artemorin\
Santamarine\
Reynosin\
Artecanin\
Tanaparthin-β-peroxideFischedick et al. ([@CR37])CPC/heptane-ethyl acetate--methanol--water (1:1:1:1)ArtemisininActon et al. ([@CR2])CCC/*iso*-octane-ethyl acetate--methanol--water (7:3:6:4)Costunolide\
DehydrocostuslactoneLi et al. ([@CR87])CCC/light petroleum--methanol--water (5:6.5:3.5)LactucopicrinWu et al. ([@CR146])CCC/*n*-hexane--ethyl acetate--methanol--water (1.5:5:2.75:5)11β,13-Dihydrolactucin\
LactucinWu et al. ([@CR146])CCC/ethyl acetate--methanol--water (20:1:20)Peroxyferolide\
LipiferolideGraziose et al. ([@CR53])CPC/*n*-hexane--ethyl acetate--methanol--water (2:1:2:1)14-(3-Methylpentanoyl)-6-deoxybritannilactone\
14-(3-Methylbutanoyl)-6-deoxybritannilactone\
14-(2-Methylpropanoyl)-6-deoxybritannilactone\
1,3-Epi-granilin\
11,13-Dihydro-inuchinenolide B\
Pulchellin C\
6-Deacetylbritanin\
4H-Tomentosin\
Gaillardin\
BritanninFischedick et al. ([@CR38])CPC/heptane--ethyl acetate--methanol--water (4:6:4:6)3β-Hydroxy-8β-\[4′-hydroxytigloyloxy\]-costunolide\
Eupalinolide A\
Eupalinolide BYan et al. ([@CR157])CCC/*n*-hexane--ethyl acetate--methanol--water (1:4:2:3)Xanthathin\
4-Epi-xanthanol\
4-Epi-isoxanthanolPinel et al. ([@CR108])CPC/*n*-hexane--ethyl acetate--methanol--water (1:1:1:1)β-CaryophylleneXie et al. ([@CR152])CCC/*n*-hexane--dichloromethane--acetonitrile (10:3:7)Rupestonic acidMa et al. ([@CR97])CCC/*n*-hexane--ethyl acetate--methanol--water (6:4:3.5:6.5) with 0.5 % acetic acid in stationary-phaseRupestonic acidYang et al. ([@CR159])CCC/*n*-hexane--ethyl acetate--methanol--water (3:5:3:5)Germacrone\
CurdioneYan et al. ([@CR156])CCC/light petroleum ether--ethanol--diethyl ether--water (5:4:0.5:1)Atractylon\
Atractylenolide IIIZhao and He ([@CR172])CCC/light petroleum--ethyl acetate--ethanol--water (4:1:4:1)NootkatoneXie et al. ([@CR153])CCC/*n*-hexane--methanol--water (5:4:1)Caryophyllene oxide\
β-Farnesene\
CaryophylleneWei et al. ([@CR144])CCC/*n*-hexane--acetonitrile--ethanol (5:4:3)(*S*)-DehydrovomifoliolYang et al. ([@CR160])CCC/*n*-hexane--ethyl acetate--methanol--water (1:5:1:5)Curdione\
Curcumol\
Germacrone\
Curzerene\
β-ElemeneDang et al. ([@CR22])CPC/light petroleum ether--acetonitrile--acetone (4:3:1)PatchoulolLi et al. ([@CR89])CPC/light petroleum ether--acetonitrile (1:1)Tussilagone\
14-Acetoxy-7β-(3′-ethyl *cis*-crotonoyloxy)-lα-(2′-methyl butyryloxy)-notonipetranone\
7aβ-(3′-Ethyl *cis*-crotonoyloxy)-lα-(2′-methyl butyryloxy)-3,14-dehydro-Z-notonipetranoneWang et al. ([@CR137])CCC/*n*-hexane--ethyl acetate--methanol--water (1:0.5:1.1:0.3)Blumenol CRoscher and Winterhalter ([@CR114])CCC/chloroform--methanol--water (7:13:8)SolanesolHu et al. ([@CR69])CCC/*n*-hexane--methanol (10:7)SolanesolDu et al. ([@CR33])CCC/light petroleum ether‐ethanol‐methanol (200:1:100)KudtdiolRodrigues et al. ([@CR113])CCC/ethyl acetate--methanol--water (2:1.75:1)8ß-Hydroxyeremophil-3,7(11)-dien-12,8α\
15,6α-Diolide and 8β-methoxyeremophil-3,7(11)-dien-12,8α;15,6α-diolide Shi et al. ([@CR120])CCC/light petroleum--ethyl acetate--methanol--water (9:1:8:2)DiterpenoidsPtaerobliquolAgostinho et al. ([@CR3])CPC/heptane--ethyl acetate--methanol--water) (6:5:6:5)Coniferin\
Coniferaldehyde glucosideSlacanin et al. ([@CR126])CPC/chloroform--methanol--water (7:13:8)Salvinorin AShirota et al. ([@CR122])CPC/*n*-hexane--dichloromethane--methanol--water (8:8:9:2)Andrographolide\
NeoandrographolideDu et al. ([@CR30])CCC/*n*-hexane--ethyl acetate--methanol--water (1:4:2.5:2.5)PhytolXiao et al. ([@CR151])CCC/*n*-hexane--acetonitrile--methanol (5:5:3)CarnosolFischer et al. ([@CR40])CCC/*n*-hexane--ethyl acetate--methanol--water (70:30:14:8)15,16-Epoxy-12-hydroxy-8(17),13(16),14-labdatrien-19-oic acid\
Imbricatolic acid\
Isocupressic acid\
Sandaracopimaric acid\
Isopimaric acidMartin et al. ([@CR100])CPC/chloroform--methanol--isopropanol--water (5:6:1:4)Kaurenoic acids\
Polyalthic acidDe Souza et al. ([@CR23])CCC/*n*-hexane--acetonitrile--ethyl acetate (1:1:0.4)Pseudolaric acid B *O*-β-[d]{.smallcaps}-glucopyranoside\
Pseudolaric acid C\
Deacetylpseudolaric acid A\
Pseudolaric acid A *O*-β-[d]{.smallcaps}-glucopyranoside\
Pseudolaric acid B\
Pseudolaric acid B methyl ester\
Pseudolaric acid A\
Pseudolaric acid HHe et al. ([@CR67])CCC/stepwise gradient: *n*-hexane--ethyl acetate--methanol--water (1:1:1:1) and (3:2:2:3) and (3.5:1:1:3.5)OridoninLu et al. ([@CR95])CCC/*n*-hexane--ethyl acetate--methanol--water (1:2:1:2)OridoninHe et al. ([@CR66])CCC/*n*-hexane--ethyl acetate--methanol--water (2.8:5:2.8:5)Oridonin\
PonicidinLu et al. ([@CR96])2D-CCC/*n*-hexane--ethyl acetate--methanol--water (1:5:1:5) in 1st direction and (3:5:3:5) in 2nd directionIsoneotriptophenolide\
Hypolide\
Triptonide\
Triptophenolide\
Triptonoterpene methyl ether VIPeng et al. ([@CR106])CCC/*n*-hexane--ethyl acetate--methanol--water (3:2:3:2)Pseudolaric acids A and B\
And their glucosides (*O*-β-[d]{.smallcaps}-glucopyranosides)Han et al. ([@CR64])CCC/*n*-hexane--ethyl acetate--methanol--water (5:5:5:5) for purification of aglicones and (1:9:4:6) for glycosides6β-Angeloyloxykolavenic acid\
6β-Tigloyloxykolavenic acidWu et al. ([@CR147])CCC/*n*-hexane--ethanol--water (6:5:1)Pseudolaric acid BHan et al. ([@CR63])CCC/*n*-hexane--ethyl acetate--methanol--water (5:5:5:5)lolitrem BGrancher et al. ([@CR52])CPC/heptane--ethyl acetate--methanol--water (33:33:24:10)Carnosic acid\
Carnosol\
Carnosaldehyde\
Epirosmanol\
Rosmanol\
12-Methoxy-carnosic acid\
SageoneFischedick et al. ([@CR39])CPC/heptane--acetone--water (3:5:2)Stevioside\
Rebaudioside A\
Rebaudioside CHuang et al. ([@CR70])CCC/*n*-hexane--*n*-butanol--water (1.5:3.5:5)Ginkgolides A\
Ginkgolides B\
Ginkgolides C\
BilobalideLiu et al. ([@CR93])CCC/stepwise gradient: *n*-hexane--ethyl acetate--methanol--water (4:5:1:5) and (4:5:2:5)Cryptotanshinone\
Tanshinone I\
Tanshinone IIAGu et al. ([@CR54], [@CR55])CCC/stepwise gradient: *n*-hexane--ethanol--water (10:5.5:4.5) and (10:7:3)Cryptotanshinone\
Tanshinone I\
1,2-Dihydrotanshinquinone\
Tanshinone IIALiang et al. ([@CR90])CCC/*n*-hexane--ethyl acetate--methanol--water (5:5:7:3)Tanshinone I\
Tanshinone IIAWu et al. ([@CR148])CCC/*n*-hexane--ethyl acetate--ethanol--water (8:2:7:3)Cryptotanshinone\
Tanshinone I\
Tanshinone IIATian et al. ([@CR131])CCC/*n*-hexane--ethanol--water (4:2:2)Dihydrotanshinone\
Cryptotanshinone\
Methylenetanshiquinone\
Tanshinone I\
Tanshinone II\
Danshenxinkun BLi and Chen ([@CR85])CCC/stepwise gradient: *n*-hexane--ethanol--water (10:5.5:4.5) and (10:7:3)Tanshinone I\
Tanshinone IIA\
Dihydrotanshinone I\
CryptotanshinoneTian et al. ([@CR132])CCC/light petroleum--ethyl acetate--methanol--water (2:3:2.5:1.7)Przewaquinone AHan et al. ([@CR61])CCC/carbon tetrachloride--methanol--water--*n*‐hexane (3:3:2:1)TriptolideYe et al. ([@CR164])CCC/*n*-hexane--ethyl acetate--methanol--water (4:5:4:5)Dihydrotanshinone I\
1,2,15,16-Tetrahydrotanshiquinone cryptotanshinone\
Tanshinone I\
Tanshinone IIA\
Neo-przewaquinone A\
MiltironeSun et al. ([@CR127])CCC/light petroleum--ethyl acetate--methanol--water (6:4:6.5:3.5) Triterpenoids2β,3β,4β-Trihydroxypregnan-16-oneRodrigues et al. ([@CR113])CCC/*n*-hexane--ethyl acetate--methanol--water (1:2:1.75:1)SqualeneLu et al. ([@CR94])CCC/*n*-hexane--methanol (2:1)Pristimerin\
NetzahualcoyeneGutiérrez et al. ([@CR56])CPC/heptane--ethyl acetate--methanol--water (8:1:6:1)GuyaninSeverino et al. ([@CR115])CCC/*n*-hexane--ethanol--acetonitrile--water (10:8:1:1)Barbinervic acid\
Rotungenic acid\
24-Hydroxy ursolic acid\
Ursolic acidFan and He ([@CR36])CCC/*n*-hexane--ethyl acetate--methanol--water (3:6:4:2)Betulinic acidFrighetto et al. ([@CR42])CCC/*n*-hexane--ethyl acetate--methanol--water (10:5:2.5:1)Ursolic acidFrighetto et al. ([@CR43])CCC/*n*-hexane--ethyl acetate--methanol--water (10:5:2.5:1)Bellericagenin B\
Bellericaside B\
Arjunglucoside I\
28-Nor-17, 22-seco-2α, 3β, 19, 22, 23-pentahydroxy-Δ 12-OleananeNasser et al. ([@CR104])CCC/chloroform--methanol--water (43:37:20)2α,3α,19β,23β-Tetrahydroxyurs-12-en-28-oic acid\
2α,3α,23β-Trihydroxyurs-12-en-28-oic acidLiu et al. ([@CR91])CCC/*n*-hexane--ethyl acetate--methanol--water (10:5:3:1)Oleanolic acid\
Ursolic acidDu et al. ([@CR29])CCC/*n*-hexane--ethyl acetate--methanol--water (3:6:2:1)ShiononeWang et al. ([@CR139])CCC/*n*-hexane--methanol (2:1)Taraxasterol acetate\
Lupeol acetate\
β-Amyrin acetateAbbott et al. ([@CR1])CCC/*n*-hexane--ethyl acetate--methanol--acetonitrile (5:2:4:5)Cycloartenyl ferulate\
24-Methylene cycloartanyl ferulateLiu et al. ([@CR92])CCC/*n*-hexane--acetonitrile (1:1)Abrusoside A, B, C, DFullas et al. ([@CR44])CCC/chloroform--methanol--water (7:13:8)No compound names givenMarston et al. ([@CR99])CCC/chloroform--methanol--water (7:13:8)Inotodiol\
Trametenolic acidDu et al. ([@CR34])CCC/*n*-hexane--ethyl acetate--methanol--water (1:0.4:1:0.4)Ursolic acid\
Ursolic acid lactoneMaurya and Srivastava ([@CR101])CPC/*n*-hexane--ethyl acetate--methanol--water (1:2:1.5:1) with 2 % ammonia solution in lower aqueous mobile phase (pH 9.5)Asiaticoside\
MadecassosideDiallo et al. ([@CR25])CCC/chloroform--*n*-butanol--methanol--water (7:3:6:4)Taraxeryl acetateYang et al. ([@CR158])CCC/chloroform--methanol--water (2:2:1)Triterpenoic acid\
Acetyl-triterpenoic acidIto et al. ([@CR75])CCC/*n*-hexane--ethanol--water (6:5:2)CelastrolWu et al. ([@CR145])CCC/light petroleum--ethyl acetate--tetrachloromethane--methanol--water (1:1:8:6:1)Asiatic acid\
Madecassic acid\
Asciaticoside\
MadecassosideDu et al. ([@CR32])CCC/*n*‐hexane--*n*‐butanol--0.05 M NaOH (5:1:6)Euscaphic acid\
Tormentic acid\
2α-Acetyl tormentic acid\
3β-Acetyl tormentic acidRocha et al. ([@CR112])CCC/gradient: *n*-hexane--ethyl acetate--methanol--water (1:2:1.25:2) and (1:2:1.5:2) and (1:2:1.75:2)Alisol B\
Alisol B 23-acetateYoon et al. ([@CR167])CPC/*n*-hexane--ethyl acetate--methanol--water (10:2:10:7)Ganoderic acids A, B, C6, D, E, F, G\
Ganoderenic acid DCheng et al. ([@CR19])CCC/stepwise gradient: light petroleum ether--ethyl acetate--methanol--water (3:5:3:5) and (4:5:4:5)\
chloroform--methanol--water (13:7:4) + ammonia (22 mM) in aqueous phase and TFA (11 mM) in organic phase for further purificationDehydrosulphurenic acid\
3-KetodehydrosulphurenicZhang et al. ([@CR169])CCC/*n*-hexane--ethyl acetate--methanol--water (1:1.5:1.2:1)24-Methylene cycloartanolYao et al. ([@CR161])CCC/*n*-hexane--ethyl acetate--acetonitrile (5:1:4)LupenoneYao et al. ([@CR161])CCC/*n*-hexane--ethyl acetate--acetonitrile (5:2:5)Triterpenoid saponins (ginsenosides)Rc, Rb1 and ReWang et al. ([@CR136])CPC/ethyl acetate--*n*-butanol--water (1:1:2)Rg3, Rk1, Rg5 and F4Ha et al. ([@CR58])CCC/methylene chloride--methanol--water--isopropanol (6:6:4:1)Rf, Rd, Re and Rb1Qi et al. ([@CR110])CCC/methylene chloride--methanol--5 mM aqueous ammonium acetate--isopropanol (6:2:4:3)ReEngelberth et al. ([@CR35])CPC/heptane--n-butanol--water (3:4:7)Rg1, Re, Rf, Rh1, Rb1, Rc, Rb2 and RdShehzad et al. ([@CR116])CCC/chloroform--methanol--water--isopropanol (4:3:2:1)Re,Rb1, Rc and Rb2Cheng et al. ([@CR18])CCC/methylene chloride--methanol--water--isopropanol (6:2:4:3, v/v) further purification of Rb1, Rc and Rb2 in *n*-hexane--*n*-butanol--0.1 % formic acid (0.7:3:4)Rb1, Rb2, Rc, Rd, Re, Rg1, Rf and Rh 1Shehzad et al. ([@CR117])CCC/stepwise gradient: *n*-hexane--ethyl acetate--methanol--water (5:6:1:4) and (4:3:1:2) and (3:3:1:2)Re and Rg1Chen et al. ([@CR16])CCC/ethyl acetate--*n*-butanol--water (4:1:6)Rh1, Rf, Rd, Rg1, Re, Rc, Rb2 and Rb1Shehzad et al. ([@CR118])CCC/methylene chloride--methanol--water--isopropanol (1:1:2:1)Rg6, Rg5, Rk1,F4, Rg3, Rg2, Rf, Rd, Rg1, Re, Rc, Rb2, Rb1Shehzad et al. ([@CR118])CCC/stepwise gradient: methylene chloride--methanol--water--isopropanol (5:4:1:3) and (2:2:1:2)Rb1 and Rb2Wang et al. ([@CR141])CPC/ethyl acetate--*n*--butanol--water (0.8:1.2:2)Rg, Rd, Re and Rb\
Notoginsenoside RCao et al. ([@CR12])CCC/chloroform--*2*-butanol--methanol--water (5:1:6:4)Rg, Rd, Re and Rb\
Notoginsenoside RCao et al. ([@CR12])CCC/ethyl acetate--*n*--butanol--water (1:1:2)Rg, Re and Rb\
Notoginsenoside RDu et al. ([@CR31])CCC/*n*-hexane--*n*-butanol--water (3:4:7)RoCheng et al. ([@CR17])CCC/ethyl acetate--isopropanol--0.1 % formic acid (3:1:5)Rg1, Re and Rb1\
Notoginsenoside R1Wang et al. ([@CR138])CPC/ethyl acetate--*n*-butanol--water (1:1:2)Triterpenoid saponinsLucyoside Q\
Lucyoside HDu and Gao ([@CR27])CCC/chloroform‐methanol‐water (13:7:8)Astragaloside I\
Astragaloside IIHan et al. ([@CR62])CCC/stepwise gradient: ethyl acetate--*2*-propanol--water (5:1:5) and (50:1:50)Lancemaside A\
Foetidissimoside A\
Astersaponin HbShirota et al. ([@CR123])CPC/*n*-hexane--*n*-butanol--methanol--0.1 % aqueous formic acid (3:4:1:6)Saikosaponins-A\
Saikosaponins-CYoon and Kim ([@CR166])CPC/ethyl acetate--*n*-butanol--methanol--water (15:1:3:1)Platycoside E\
Deapio-platycoside EHan et al. ([@CR64])CCC/*n*-hexane--*n*-butanol--water (1:40:20)Platycodin D3\
Deapio-platycodin D3\
Platycodin D\
Deapio-platycodin DHan et al. ([@CR64])CCC/*n*-hexane--*n*-butanol--water (1:10:5)2″-*O*-Acetylplatycodin D\
3″-*O*-Acetylpolygalacin D\
2″-*O*-Acetylpolygalacin\
3″-*O*-Acetylplatycodin D\
Polygalacin DHa et al. ([@CR59])CCC/chloroform--methanol--isopropanol--water (3:2:2:3)No compound names givenShi et al. ([@CR119])CCC/ethyl acetate--*n*-butanol--ethanol--0.05 % TFA (5:10:2:20)Astragaloside IV\
Astragaloside II\
Astragaloside I\
Acetylastragaloside IPeng et al. ([@CR107])CCC/stepwise gradient: *n*-hexane--ethyl acetate--ethanol--water (1:0.6:0.6:1) and (1:1:1:1)Gypsogenin derivatives\
Dianoside CYao et al. ([@CR162])CCC/*n*-hexane--*n*-butanol--methanol--0.02 % TFA (1:9:1:9)Hederagenin\
3-*O*-\[β-[d]{.smallcaps}-xylopyranosyl-(1→3)-α-[l]{.smallcaps}-rhamnopyranosyl-(1→2)-[l]{.smallcaps}-arabinopyranosyl\]-hederageninXin et al. ([@CR154])CCC/*n*-hexane--ethyl acetate--methanol--water (7:3:5:5)23-*O*-Acetylshengmanol-3*O*-[d]{.smallcaps}-xylopyranoside\
Cimiracemoside D 25-*O*-acetylcimigenol-3-*O*-[d]{.smallcaps}-Xylopyranoside\
CimigenolCicek et al. ([@CR20])CCC/*n*‐hexane--acetone--ethyl acetate--isopropanol--ethanol--water (3.5:1:2:1:0.5:2)Esculentosides A, B, C, and DMa et al. ([@CR98])CCC/chloroform--methanol--water (4:4:2)HederageninCCC/heptane--acetone--methanol (5:1:4)HederageninHe et al. ([@CR65])CPC/*n*-hexane--ethyl acetate--methanol--water (7:8:5:3)Elatoside FLee et al. ([@CR83])CCC/chloroform--methanol--water--isopropanol (4:3:3:1)Tormentic acidWang et al. ([@CR140])CCC/*n*-hexane--ethyl acetate--methanol--water (4:5:4:5)Arganine A, C, D\
TieghemelinGosse et al. ([@CR50])CCC/*tert*-butylmethyl ether--*n*-butanol--acetonitrile--0.5 % TFA (1:3:3:5)Triacetyl soyasaponin Ab, Aa, Ab, Ae, Ba, Af, Bb, Be and conjugated groups, αg, βg and γgZhao et al. ([@CR173])CCC/*n*-butanol--acetic acid--water (5:0.05:5)-acid in *n*-butanol as stationary phaseLicorice-saponin A3\
Glycyrrhizic acid, 3-*O*-\[β-[d]{.smallcaps}-glucuronopyranosyl-(1→2)-β-[d]{.smallcaps}-Galactopyranosyl\]glycyrrhetic acidXu et al. ([@CR155])CCC/ethyl acetate--*n*-butanol--water (2:3:5) with 10 mM TFA in the upper organic\
Stationary phase and 10 mM ammonia in the lower aqueous mobile phaseGlycyrrhizinJiang et al. ([@CR77])CCC/ethyl acetate--methanol--water (5:2:5)Goyaglycoside-E\
Momordicoside L\
Goyaglycoside-a\
Momordicoside KDu and Yuan ([@CR28])CCC/*tert*-butylmethyl ether--*n*-butanol--methanol--water (1:2:1:5) or (1:3:1:5)TetranortriterpenoidsAzadirachtin A\
Azadirachtin B\
Azadirachtin H\
Desacetylnimbin\
Desacetylsalannin\
Nimbin\
SalanninSilva et al. ([@CR124])CCC/*n*-hexane--*n*-butanol--methanol--water (1:0.9:1:0.9)Methyl angolensate\
7-Descetoxy-7-oxogedunin\
Deacetylgedunin\
6α-Acetoxygedunin\
Gedunin\
Andirobinda Silva et al. ([@CR21])CCC/stepwise gradient: *n*-hexane--ethyl acetate--methanol--water (2:1:1.5:1) and (2:1:1.75:1)Tetraterpenoids (Carotenoids)Cochloxanthin\
DihydrocochloxanthinDiallo and Vanhaelen ([@CR24])CCC/tetrachloromethane--methanol--water (5:4:1)ZeaxanthinChen et al. ([@CR14])CCC/*n*-hexane--ethyl acetate--ethanol--water (8:2:7:3)CrocinJiang et al. ([@CR78])CCC/*tert*-butylmethyl ether--*n*-butanol--acetonitrile--water (2:2.5:1:5)FucoxanthinKim et al. ([@CR79])CPC/*n*-hexane--ethyl acetate--ethanol--water (5:5:7:3)LuteinWei et al. ([@CR143])CCC/*n*‐heptane--chloroform--acetonitrile (10:3:7)Zeaxanthin\
LuteinAman et al. ([@CR5])CCC/*n*-hexane--ethanol--water (6:5:1.3)LuteinTsao and Yang ([@CR133])CCC/*n*-hexane--ethanol--water (6:4.5:1.5)CanthaxanthinLi et al. ([@CR88])CCC/*n*-hexane--ethanol--water (10:9:1)9′-*Cis*-neoxanthinBaldermann et al. ([@CR6])CCC/*n*-hexane--ethanol--water (5:5:4.5)LycopeneBaldermann et al. ([@CR7])CCC/*n*-hexane--dichloromethane--acetonitrile (30:11:18) with 85 mg/L of 3-tert-butyl-4-hydroxyanisol and 2-tert-butyl-p-cresolCrocins 1, 2, 5\
PicrocrocinLechtenberg et al. ([@CR82])CPC/*n*-hexane--ethyl acetate--ethanol--water (1:3:4:7)FucoxanthinXiao et al. ([@CR150])CCC/*n*-hexane--ethyl acetate--ethanol--water (5:5:6:4)LuteinLi et al. ([@CR86])CCC/*n*-hexane--ethanol--water (4:3:1)LycopeneWei et al. ([@CR142])CCC/*n*-hexane--dichloromethane--acetonitrile (10:3.5:6.5)AstaxanthinLi and Chen ([@CR84])CCC/*n*-hexane--ethyl acetate--ethanol--water (5:5:6.5:3)Tephrosin\
Deguelin\
6a,12a-DehydrodeguelinYe et al. ([@CR163])CCC/*n*-hexane--ethyl acetate--methanol--water (1:0.8:1:0.6)*CCC* counter-current chromatography, *CPC* centrifugal partition chromatography

The solvent systems tables mentioned above are presented here, sorted according to class of terpenoid separated. That table is presented for the benefit of CCC users by suggesting possible suitable solvent systems, which can act as a starting point for further refinement and optimization in the composition of the system.

Applications of high speed and high performance CCC {#Sec5}
===================================================

Being a liquid--liquid chromatography system, CCC can select from an almost infinite range of possible two-phase solvent systems for a purification. Most reported purifications with the technique have understandably concentrated on compounds of intermediate polarity. For example, a review of Chinese herbal medicines purified by CCC found a total of 214 different compounds in 198 published papers with a LogP polarity range from −4 to +12 (Sutherland and Fisher [@CR129]). However, more than 60 % of those compounds fell in the narrow intermediate polarity range of 0--4. Nevertheless, CCC and its sister technique, CPC can be particularly useful for purifications in the extreme polar and non-polar range and some impressive examples have been published. In 1995, Gasper and co-workers managed to purify C~60~ and C~70~ fullerenes using the non-polar and non-aqueous solvent system of isooctane, dimethylformamide, 1,2-dichlorobenzene (4:2:1) plus 1 % *tert*-butylmethyl ether (Gasper et al. [@CR48]). Still at the non-polar end of the spectrum, the carotenoid lycopene was isolated from tomato paste using a non-aqueous phase system of *n*-hexane, dichloromethane and acetonitrile (10:3.5:6.5) (Wei et al. [@CR142]). This separation was performed in a single step from the crude material with 100 mg of crude extract injected onto a 230 ml capacity centrifuge. The purity of the final product was measured as \>98 % by HPLC peak area. Lycopene has a calculated LogP value of approximately 17.6. Beyond the carotenoids, non-polar terpenoids can also be challenging to purify with solid phase chromatography, and again CCC offers an alternative approach. In one example, Liu et al. ([@CR92]) successfully separated cycloartenyl ferulate and 24-methylene cycloartanyl ferulate. Due to the weak polarity, a series of low-polar solvent systems, including: *n*-hexane--ethyl acetate--ethanol (methanol)--water, *n*-hexane--ethanol (methanol)--water, *n*-hexane--methanol and *n*-hexane--ethyl acetate--*n*-butanol ethanol (methanol)--water were tested, but all without success. Since the HPLC mobile phase for the analysis of those two target compounds consisted of methanol, acetonitrile and isopropanol, these three solvents were further studied and a mixture of hexane and acetonitrile (1:1) was used for the purification. Another application of non-aqueous solvent systems is the purification of shionone---also a low-polar compound. Wang et al. ([@CR139]) tested several hydrophobic two-phase solvent systems. Among these *n*-hexane--methanol (2:1) and heptane--dichloromethane--acetonitrile (20:7:13) were suitable for the separation.

Turning to the extreme polar end of the spectrum, CCC has been used with aqueous-organic solvent systems for the purification of peptides. For example, the peptide antibiotic colistin (LogP about −4.7) was isolated from a commercial microbial preparation using the polar two-phase system consisting of *n*-butanol and 0.04 M aqueous trifluoroacetic acid (1:1) (Ikai et al. [@CR72]). Using the salt-based solvent system consisting of 1-propanol, acetonitrile, saturated ammonium sulphate and water (1:0.5:1.2:1) the highly polar glucosinolate glucoraphanin was purified to a purity \>98 % from a crude broccoli extract in a single step (Fisher et al. [@CR41]).

Sometimes modifications are necessary. The separation of three closely related triterpenes: sericic acid, trachelosperogenin E and sericoside was achieved using a three-phase solvent system composed of *n*-heptane, *tert*-butylmethyl ether, acetonitrile and water. After mixing all solvents in equal volume, the upper phase was separated and *tert*-butylmethyl ether was shaken with the remaining two-phase solvent system in order to decrease the polarity. The lower phase was used as a stationary phase. Sericic acid was identified in the fractions collected when the upper phase was used as the mobile phase, while the elution of the middle phase led to the separation of trachelosperogenin E and sericoside (Hamzaoui et al. [@CR60]).

Zhao and Du ([@CR171]) proposed a novel non-aqueous two-phase solvent system composed of sunflower oil and ethanol to separate solanesol---a non-cyclic terpene alcohol used as a food additive for preventing cardiac arrest and cancer. Before, this target molecule was purified from tobacco leaves extract with petroleum and methanol, both solvents being unsuitable for the food industry.

Sometimes the addition of a small amount of acid can significantly improve the purification. Shirota et al. ([@CR123]) purified the saponins lancemaside A, foetidissimoside A and astersaponin Hb from a hot water extract of *Codonopsis lanceolata* roots used CPC with mixture of *n*-hexane--*n*-butanol--methanol--0.1 % aqueous formic acid (3:4:1:6) as the two-phase solvent system. Because the crude extract contained large amounts of sugars, an aqueous phase was chosen as the stationary phase so that these sugars would be retained in the partition cells, whereas an organic phase was chosen as mobile phase for elution of the target compound. Addition of formic acid to the two-phase solvent system retained the carboxy group in the non-ionised form and allowed the separation of the lancemasides from the large amounts of water-soluble sugars present. The addition of acetic acid to the ethyl acetate--*n*-butanol--water mixture improved the resolution of soyasaponins, naturally occurring triterpenoid glycosides. A suitable mixture *n*-butanol, acetic acid, water (5:0.05:5) was taken but acetic acid was added only in *n*-butanol as the stationary phase (Zhao et al. [@CR173]). During the separation, with the movement of the mobile phase the acetic acid was gradually diluted with water and the polarity of the stationary phase changed as a gradient. It is worth mentioning that the main difficulties with soyasaponin isolation and purification are that the soyasaponins coexist in soybeans with the isoflavone glycosides and they share overlapping polarities. There is also the structural similarity of soyasaponin compounds.

CCC is popularly applied for purification of ginsenosides, an important group of terpenoids due to their biological activity. They generally fall in the moderate to polar category and therefore require similar solvent systems for purification (Qi et al. [@CR110]; Shehzad et al. [@CR118]). A good solubility for saponin-like compounds can be provided by the addition of chloroform or other chlorinated solvents and a gradual polarity change between phases can be achieved by varying the methanol ratio in the system or by adding another alcohol like isopropanol (Qi et al. [@CR110]). Shehzad et al. ([@CR118]) proposed an efficient CCC separation method in which a flow-rate gradient technique was coupled with a new solvent gradient dilution strategy for the isolation of ginsenosides from Korean red ginseng (steam-treated *P. ginseng*). The column was first entirely filled with the upper stationary phase mixture of methylene chloride--methanol--isopropanol--water (5:4:1:3) in a reversed phase system. After 300 min, when five ginsenosides had eluted, the flow rate was increased from 1 to 1.2 ml/min and also the dilution of the lower phase was initiated and was changed to 100 % of lower phase composed of the mixture mentioned above in a ratio (2:2:1:2). Overall, 13 ginsenosides including Rg1, Re, Rf, Rg2, Rb1, Rb2, Rc, Rd, Rg3, Rk1, Rg5, Rg6, and F4 were purified (Shehzad et al. [@CR118]). Qi et al. ([@CR110]) for the purification of ginsenosides Rf, Rd, Re and Rb1, applied mixtures of methylene chloride, methanol, water and isopropanol (6:2:4:3).

Emulsification can often be a problem in the CCC purification of ginsenosides. Generally, adding an electrolyte, such as salt or acid, can help to eliminate such emulsification. Salt is not recommended because an additional desalting process will be necessary after the separation. Therefore, formic acid is often chosen to prevent emulsification (Cheng et al. [@CR17]). However, Qi et al. ([@CR110]) preferred to avoid an acidic environment, which would lead to the decomposition of ginsenosides. Instead, the inorganic salt ammonium acetate was chosen, because it is volatile and can be precipitated in warm acetone for sample recovery. The addition of this salt resulted in a very slight decrease in *K* values and thus a shorter separation time. In the end, the proposed solvent system was methylene chloride--methanol--5 mg/mL aqueous ammonium acetate--isopropanol (6:2:4:3).

As the solvent system contained methylene chloride and methanol, both toxic to humans and the environment, Wang et al. ([@CR136]) chose low toxic solvents such as ethyl acetate and *n*-butanol. Since the ginsenosides in *P. quinquefolium* L. have a comparatively larger polarity with solubility in hydrophilic solvents, both phases require a certain hydrophilicity to get a good separation. Initially, the hexane--*n*-butanol--water solvent systems were scanned at several volume ratios, but all the systems had a poor retention in the CPC column. Then ethyl acetate was then employed instead of hexane in order to enhance the retention of the stationary phase in the column. Because ginsenosides are easily dissolved in *n*-butanol, and the viscosity of *n*-butanol is comparatively large, so in an ethyl acetate--*n*-butanol--water solvent system, the addition of *n*-butanol could delay the peak elution time and affect the separation. Overall, the system of ethyl acetate--*n*-butanol--water (1:1:2) was used for successful separation of three ginsenosides Rc, Rb1, and Re.

Counter-current chromatography has also been used for the separation of minor and structurally similar compounds. Fan and He ([@CR36]) using HSCCC with *n*-hexane--ethyl acetate--methanol--water (3:6:4:2) to separate not only ursolic acid, which is a very small content of the leaves of *Diospyros kaki*, but also two other pentacyclic triterpenes: barbinervic acid and its epimer rotungenic acid, differing only with the configuration of a hydroxyl group at position C3: one contains an axial and the other an equatorial hydroxyl group. HSCCC was also employed for the separation and purification of minor constituents in *Platycodi Radix*. Platycosides, the saponins that are the major active constituents, are typically composed of oleanene backbones with two side chains; one a glucose unit attached through an ether linkage at the C-3 position of a triterpene, and the other 28-*O*-arabinoserhamnose-xylose-apiose linked by an ester bond. They also have different substituents at the C-4 position. Because the content of these compounds is very low, conventional methods are frequently not suitable for the separation. Ha et al. ([@CR59]) used a two-phase solvent system consisting of chloroform--methanol--isopropanol--water (3:2:2:3) for purification of minor saponins 2″-*O*-acetylplatycodin D, 3″-*O*-acetylpolygalacin D, 2″-*O*-acetylpolygalacin and a mixture of 3″-*O*-acetylplatycodin D and polygalacin D, which were further successful purified using prep-HPLC (Ha et al. [@CR59]). Ha and Kim ([@CR57]) also used HSCCC for the separation of three pairs of platycosides and their deapiose forms. They used an interesting modification: the column was first filled with a mixture of the two phases, thus reducing the amount of time for hydrodynamic equilibrium to be established. The ratio of two phases was optimised at 70:30 (stationary phase--mobile phase) based on the amount of time required to reach hydrodynamic equilibrium. A series of solvent systems were tested. In the gradient elution mode, the retention of the stationary phase was extremely low. The authors decided to perform the separation in two stages. First, platycoside E, deapio-platycoside E, a mixed fraction containing platyodin D and deapiose form, and a fraction containing platycodin D3 and deapiose form were separated using the *n*-hexane--butanol--water (1:40:20) in reversed-mode. Then mixed fractions I and II were further purified in the normal elution mode with the above mentioned solvent system in the ratio 1:10:5.

CCC/CPC seems to be one of the few efficient approaches for the separation of xanthanolides, a bicyclic subtype of sesquiterpenic lactones characterized by a 5,7-fused system containing a γ-lactone moiety. Because of some well documented and promising activity purification of these compounds is important. The presence of several chiral centres probably explain the difficulty obtaining enantiomericaly pure xanthanolides by total synthesis, thus purification from natural source seems to be the best solution. Xanthonolides are coextracted with chlorophyll and lipids. The pigment crystallization and the delipidation in order to clean the extract is not selective and cause the partial loss of target compounds. Purification of several xanthanolides (xanthathin, 4-*epi*-xanthanol and 4-*epi*-isoxanthanol) was realized in one step, directly from the crude chloroformic extract of the leaves of *X. macrocarpum* with a mixture of heptane--ethyl acetate--methanol--water (1:1:1:1) (Pinel et al. [@CR108]).

High-speed counter-current chromatography can be applied as a method suitable for fingerprinting. Gu et al. ([@CR55]) used it for quality control of TCMs and identification of the active compounds of *Salvia miltiorrhiza* Bunge, a popular traditional Chinese medicine. In order to purify a series of tanshinones a stepwise elution with solvent systems composed of *n*-hexane--ethanol--water (10:5.5:4.5) and (10:7:3) was used. The method was compared with more conventional approaches, such as high performance liquid chromatography (HPLC), high performance capillary electrophoresis (HPCE), and thin-layer chromatography scan (TLCS). In the HSCCC separation, 12 components were separated, with good resolution and precision, within 13 h. HSCCC showed better performance in the analysis of tanshinones, which produced a fingerprint which contained more chemical information than that of e.g. TLCS.

Lu et al. ([@CR96]) proposed this effective two-dimensional counter-current chromatographic method for the simultaneous isolation and purification of oridonin and ponicidin from a crude extract of *Rabdosia rubescens* with a pair of two-phase solvent systems composed of *n*-hexane--ethyl acetate--methanol--water (1:5:1:5 and 3:5:3:5, v/v). A combination of stepwise CCC and pH-zone-refining is also possible. Cheng et al. ([@CR19]) reported its successful combination in the separation of the main components from *G. lucidum*. In the first step, a two-phase solvent system composed of petroleum ether--ethyl acetate--methanol--water (3:5:3:5 and 4:5:4:5) led to the separation of ganoderic acids GE, GC6 and GF with high purity in one run. Also two peaks containing GG, GB, GA and GED, GD, respectively, were collected and their separation was followed by pH-zone-refining CCC. Chloroform--methanol--water (13:7:4) with NH~4~OH in upper aqueous stationary phase and trifluoroacetic acid as the eluter acid was the most suitable. In another example of two-dimensional CCC, a three-step gradient elution and two-step flow-rate gradient elution was applied to separate 8 diterpene compounds within 80 min in a single run from the alcohol extract of *Pseudolarix kaempferi*. Pseudolaric acid B *O*-β-[d]{.smallcaps}-glucopyranoside, pseudolaric acid C, deacetylpseudolaric acid A, pseudolaric acid A *O*-β-[d]{.smallcaps}-glucopyranoside, pseudolaric acid B, pseudolaric acid B methyl ester, pseudolaric acid A and pseudolaric acid H were obtained with very high purity (He et al. [@CR67]). The separation was performed in normal phase system. In the first step, the mobile phase, composed of hexane--ethyl acetate--methanol--water (1:1:1:1), was used with a flow rate 0.5 ml/min. While the mobile phase (upper) of (2:3:2:3) and (1:3.5:1:3.5) were used in the second and third step, and the flow rate of mobile phase was set at 1 ml/min. When the separation was performed in preparative conditions, the initial flow rate of mobile phase was 25 ml/min in the first step and then increased to 50 ml/min in the second and third step.

Principle advantages and drawbacks of CCC in the purification of natural products {#Sec6}
=================================================================================

Counter-current chromatography has a number of key advantages in the purification of natural products. For example, the solvent usage is generally far lower than that of solid phase chromatography systems operating at the same scale (about 25 %) (Graham et al. [@CR51]). Furthermore, since the process is frequently an isocratic one, a simple analysis of solvent composition allows the recycling of the solvents, reducing the usage still further (Garrard et al. [@CR46]). The technique also allows for 100 % recovery of the sample components. In other words, the target compound can always be retrieved since there is no solid phase and therefore no possibility of losses arising from irreversible adsorption onto the solid matrix. This is a significant advantage in every purification process. As a solid-free and therefore relatively gentle chromatographic technique, CCC can be used for the isolation of unstable natural compounds. Baldermann et al. ([@CR6]) presented the successful purification of 9′-*cis*-neoxanthin, the predominant isomer of neoxanthin in green vegetables. Major problems during its isolation include isomerization and oxidation, mainly caused by higher temperatures, light or oxygen exposure. When typical solid stationary phase techniques are applied, the rearrangement products can be detected or complete isomerization can be observed. A solid-free technique is a very practical solution for avoiding the above mentioned complications.

Particulates, such as cell debris, are generally well tolerated in CCC, particularly when performed at large scale where the tubing bore may be up to 10 mm in diameter. This is another major advantage over solid phase chromatography systems. Thus filtering a sample is frequently not necessary, depending on the scale of CCC employed, and even if it is required, it is usually a simple filter paper filtration. With processing times similar to that of other purification methods, scale up is also possible with modern instruments with examples existing running from milligram to kilogram levels (Garrard et al. [@CR47]). The technique can be operated in normal batch injection mode, or as a continuous extraction process for better throughput. A wide range of polarities can be processed due to the range of solvents that may be used (the literature reports examples with a logP range from −4.7 (colistin peptide antibiotic) (Ikai et al. [@CR72]) to +17.6 (lycopene) (Wei et al. [@CR142]). Also, the separation of compounds with vastly different polarities from a single extract is possible. For example, in order to purify a wide range of polarity of triterpene saponis from *Panax notoginseng*, Zhang et al. ([@CR170]) successfully coupled accelerated solvent extraction (ASE) and high-performance counter-current chromatography (HPCCC). First the upper phase of the solvent system ethyl acetate--*n*-butanol--water (1:1:2 or 1.2:1:2) or ethyl acetate--*n*-butanol--methanol--water (3:5:1.5:6) was used as both the ASE solvent and HPCCC stationary phase. The polar saponis were eluted. In order to separate fractions with moderate polarity, the upper phase of system ethyl acetate--*n*-butanol--methanol--water (6:3:2:6 or 7:3:2:7) was used. Finally, the upper phase of the solvent system of *n*-hexane--*n*-butanol--methanol--water (8:2:2:8) or *n*-hexane--ethyl acetate--*n*-butanol--methanol--water (0.2:10:0.5:1.5:8) was used as both the ASE solvent and HPCCC stationary phase to elute the low polar compounds. This combination of methods allowed the purification of notoginsenosides R6, R1, Spt1 and ginsenosides Rb1, F4, Rh3, Rg3, Rs3 and Rk1 with a wide range of polarity (Zhang et al. [@CR170]).

Compared to the early instruments, the quality of modern CCC apparatus is very good. In most cases the coils are tough and the machinery robust. A set of coils would be expected to last the lifetime of the centrifuge and maintenance and running costs are low. Unlike solid phase chromatography, there is no change to component retention over time (no column aging effects) as a freshly-filled coil of solvents is used each run. This makes it easier to consistently satisfy current regulatory requirements when performing purifications under a good laboratory practice (GLP) or good manufacturing practice (GMP) environment.

As has been seen in a number of quoted examples, a large advantage of CCC is that the technique can be operated in a number of different modes, since both the mobile and the stationary phase are liquid. Either normal or reverse phase chromatography can be chosen, depending on which solvent phase is selected to be the mobile one. However, it is even possible to switch from normal phase elution to reverse phase (or vice versa) in the middle of a run. Intermittent counter-current extraction (ICCE) is a continuous process where the operation alternates between normal and reverse phase mode at regular intervals, with the sample continuously introduced in the middle of the coil (Hewitson et al. [@CR68]). In the reference quoted, this technique was successfully used to purify a diterpenoid, triptolide, a high value target compound, from a Chinese herbal plant, from 2 % in the crude extract to over 98 % purity. This was achieved by retaining and enriching the target compound within the CCC coil while washing away all the other components of the crude material. Alternatively, components can be recovered by eluting the liquid stationary phase without any compound losses whilst maintaining resolution (Berthod et al. [@CR10]), a technique known as elution-extrusion. This technique is frequently adopted at the end of standard CCC purification runs simply to ensure that no loss of target compound has occurred within the liquid stationary phase. Another possibility is co-current chromatography (Berthod and Hassoun [@CR9]) where both phases are pumped in the same direction. All of these options use a conventional CCC centrifuge and are thus easy to implement in the laboratory or pilot plant. However, with modifications to the CCC coils, continuous counter-current extraction (CCCE) is possible, where one phase is pumped in the opposite direction to the other and the sample is introduced continuously into the centre of the coil (Ito et al. [@CR76]; Van den Heuvel [@CR134]).

The method also allows a two dimensional procedure to be applied. The purification of very similar terpene lactones from *G. biloba* L, such as bilobalide, ginkgolides A, B, C, and J, is an example. The partitioning experiment assisted the design of a 2D procedure using a pair of orthogonal solvent systems: chloroform--methanol--water (10:7:3) and hexane--ethyl acetate--methanol--water (4:6:4:6) with addition of 0.5 % DMSO to increase the resolution of ginkgolides A and B. This approach separated these almost equipolar lactones (Qiu et al. [@CR111]).

The main drawbacks of the technique, particularly when compared to preparative HPLC and other solid phase chromatography techniques, include a lower efficiency. When measured in terms of theoretical plates, the efficiency of a "good" CCC apparatus is in the low thousand plate range. This figure cannot be directly compared to HPLC plate counts due to the much higher percentage of stationary phase (around 80 % compared to perhaps 5 % active stationary phase sites in HPLC) and the resolution of CCC can be extremely good. However, a low efficiency results in broad peaks, making the technique far more suited to a preparative application as opposed to an analytical one. Also the narrow polarity range within each run should be emphasised. As mentioned above, a wide range of polarities can be processed by CCC by using different solvent systems. However, a single CCC run operates over a relatively narrow polarity window. Although some examples of gradient elution have been reported (see Table [2](#Tab2){ref-type="table"}), these do not give as wide a polarity range as that achievable with HPLC. The narrow polarity window can be used to advantage when it is desired to pluck a single target compound from a complex mixture. However, it is a disadvantage when a dozen pure compounds are required from the mixture in a single purification run. The CCC apparatus does not inherently lend itself to easy automation and thus its operation can appear labour-intensive. In addition, the instruments have not received the same intensive commercial development that has made modern HPLC and GC equipment so sophisticated. This situation will undoubtedly improve in the future, with advances in CCC machine design. Finally, the solvent system selection is undoubtedly time-consuming. As the two phases are liquid, changes in one phase directly affects the other. Analysis of a range of possible solvent systems can be performed by an automated liquid-handling robot but this still requires a number of hours to complete. This is a current area of research in the field and no doubt large improvements in solvent system selection time can be expected over the next few years.

Conclusions {#Sec7}
===========

Although initially dismissed by many chemists and purification scientists as slow, unreliable and temperamental, steady development of the technique of CCC on both the engineering and the application side has transformed it into a technique worthy of inclusion in the natural product scientist's arsenal. On one side, engineering developments have produced machines that are robust, capable of fast, efficient separations and able to accept high injection loadings. On the other side, developments in the application protocols have produced modes of operation and solvent systems to purify out compounds from the full polarity spectrum. Combined, these have produced a technique that is wonderfully suited to natural product purifications, particularly on a large preparative scale, with advantages over solid phase techniques such as the ability to accept particulates and to always recover all components, and advantages over the old-style liquid--liquid techniques such as high speed, high loading and high resolution. To assist users of CCC and those wishing to experiment with the technique, a comprehensive phase selection table has been generated by distilling the solvent system information presented from CCC terpenoids purifications over the last 30 years.
